111 results
Page 4 of 6
424B5
6vsbf
22 Jan 19
Prospectus supplement for primary offering
4:43pm
8-K
EX-1.1
dtzgd1o
16 Jan 19
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
5:25pm
424B5
5z3qs0 nj0b4v34nvh
16 Jan 19
Prospectus supplement for primary offering
5:23pm
424B5
1bsla688vfhoay9u25q6
14 Jan 19
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
gcqrk
3 Dec 18
Regulation FD Disclosure
4:29pm
8-K
EX-99.1
octotn4c 4l2k
15 Nov 18
Bio-path Holdings Reports Third Quarter 2018 Financial Results
7:05am
8-K
EX-99.1
ohn tb7vuz5mtz
2 Nov 18
Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting
4:34pm
8-K
9qax0zawcnx1b1mp3
2 Nov 18
Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting
4:34pm
8-K
EX-10.1
02d3p
21 Sep 18
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-99.1
4ysgfxay5f
16 Aug 18
Bio-Path Holdings Appoints Dr. Jason B. Fleming to Scientific Advisory Board
1:04pm
8-K
EX-99.1
3dhgigs7z7m7850g
10 May 18
Bio-Path Holdings Appoints Dr. Anas Younes to Scientific Advisory Board
5:02pm